Company: SGBAF
Filing Date: 2025-01-17
Form Type: DRS/A
Source: 0000950123-25-000378
Chunk: 389

Company: SES S.A.
Filing Date: 2025-01-17
Form: DRS/A
Chunk 389
---
 of December 31, 2021 to $30.7 million as of February 28, 2022. Net periodic other postretirement benefit costs (income) included the following components (in thousands):

|                                                    |     | Other Postretirement Benefits 
 Predecessor                   |   Year Ended 
 December 31, 
         2021 |   |     |   |   Two Months 
        Ended 
 February 28, 
         2022 |   |     | Successor |   Ten Months 
        Ended 
 December 31, 
         2022 |     |   |   Year Ended 
 December 31, 
         2023 |   |
|:---------------------------------------------------|:----|:------------------------------|-------------:|:--|:----|:--|-------------:|:--|:----|:----------|-------------:|:----|:--|-------------:|:--|
| Interest cost                                      |     | $                             |          596 |   |     | $ |          115 |   |     | $         |          704 |     | $ |        1,307 |   |
| Amortization of unrecognized prior service credits |     |                               |       (2,545 | ) |     |   |         (423 | ) |     |           |            — |     |   |            — |   |
| Amortization of unrecognized net gain              |     |                               |       (1,386 | ) |     |   |         (264 | ) |     |           |            — |     |   |         (113 | ) |
| Net periodic benefit expense (income)              |     | $                             |       (3,335 | ) |     | $ |         (572 | ) |     | $         |          704 |     | $ |        1,194 |   |

We had accrued benefit costs at December 31, 2022 and 2023 of $25.8 million and $22.1 million, respectively, related to the other postretirement benefits, of which $2.5 million and $2.2 million were recorded within “Other current liabilities” as of December 31, 2022 and 2023, respectively, and $23.3 million and $19.9 million were recorded in “Other long-term liabilities,” respectively, in our consolidated balance sheets. Depending on our actual future health care claims, our actual costs may vary significantly from those